Belite Share Price

Belite Share Price

NASDAQ: BLTE | Others
$127.02
-$24.83 (-16.35%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Belite Stock Performance

Open
$124.95
Prev. Close
$151.85
Circuit Range
N/A
Day Range
$122.50 - $135.00
Year Range
$108.01 - $199.70
Volume
66,268
Average Traded
$130.47

Belite Share Price Today

As of 22 November 2026, Belite Bio, Inc's share price is $127.02. The stock opened at $124.95, compared to its previous close of $151.85. During today's trading session, Belite Bio, Inc's share price traded between $122.50 and $135.00, with an average price of $128.75. Over the past 52 weeks, the stock has recorded a high of $199.70 and a low of $108.01. In terms of performance, Belite Bio, Inc's share price has declined by 11.89% over the last six months and is down 7.72% on a year-on-year basis.

Belite Share Price Chart

Line chart of the Belite price trend over the selected period. The price fell overall, ranging from 122.50 to 135.00, ending at 127.02.
$122.50$135.00
L
Show Current Price
H

Belite Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Belite Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$12.65-$31.63-$36.14-$77.61
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-150.04%-14.26%-114.75%

Belite Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets286.285.064.71.47
Current Assets494.27147.0789.9442.81
Total Assets780.56152.1394.6444.27
Non Current Liabilities0.190.260.580.67
Current Liabilities9.886.053.632.1
Total Liabilities10.076.314.212.77
Shareholders' Equity770.49145.8290.4341.5

Belite Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-36.99-29.23-29.84-11.46
Investing-305.11-110.57-0.06-0.39
Financing663.2383.675.9636.96

About Belite

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Belite Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$157.00
$126.79
-18.67%
Oct 2026
$169.83
$155.90
-8.73%
Sep 2026
$154.37
$170.82
+8.74%
Aug 2026
$155.00
$157.09
-1.11%
Jul 2026
$155.56
$158.86
+3.22%
Jun 2026
$136.70
$153.90
+6.75%
May 2026
$157.75
$144.16
-9.46%
Apr 2026
$164.25
$159.22
-0.15%
Mar 2026
$178.00
$159.46
-16.43%
Feb 2026
$169.31
$190.80
+13.07%
Jan 2026
$160.00
$168.74
+5.83%
Dec 2025
$154.00
$159.44
+15.84%

Belite Share Price FAQs